Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
February 10, 2009

DSM and Crucell Sign On Bioceros as Generation Partner of PER.C6 Cell-Line Proteins

  • Bioceros joined DSM Biologics and Crucell’s vendor network. Bioceros is now a preapproved cell-line generation partner for licensees of the PER.C6® cell line located in the EU. “The growing number of PER.C6 licensees requires that we expand the possibilities for our licensees to obtain services like cell-line generation,” notes Karen King, president of DSM.

    The PER.C6 technology platform has been developed for the large-scale manufacture of biopharmaceutical products such as recombinant proteins including mAbs. By employing the PER.C6 human cell line and DSM's XD™ technology, a record yield of over 27 grams per liter in the production of IgG antibodies has been achieved, according to the firms.

Related content